Clostridium difficile in Long-Term–Care Facilities for the Elderly

Abstract Antimicrobial agents are among the most frequently prescribed medications in long-term–care facilities (LTCFs). Therefore, it is not surprising that Clostridium difficile colonization and C. difficile-associated diarrhea (CDAD) occur commonly in elderly LTCF residents. C. difficile has been identified as the most common cause of non-epidemic acute diarrheal illness in nursing homes, and outbreaks of CDAD in LTCFs have also been recognized. This position paper reviews the epidemiology and clinical features of CDAD in elderly residents of LTCFs and, using available evidence, provides recommendations for the management of C. difficile in this setting.

[1]  M. Wilcox,et al.  Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. , 2001, The Journal of hospital infection.

[2]  Matthew R. Thomas,et al.  Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. , 2001, Mayo Clinic proceedings.

[3]  R. Barker,et al.  GT160-246, a Toxin Binding Polymer for Treatment ofClostridium difficile Colitis , 2001, Antimicrobial Agents and Chemotherapy.

[4]  E. Jones,et al.  Bacterial contamination of uniforms. , 2001, The Journal of hospital infection.

[5]  D. Pardi,et al.  Clostridium difficile-associated diarrhea and colitis. , 2001, Mayo Clinic proceedings.

[6]  M. Wilcox,et al.  Molecular epidemiology of endemic Clostridium difficile infection , 2001, Epidemiology and Infection.

[7]  M. Wilcox,et al.  Role of antibody response in outcome of antibiotic-associated diarrhoea , 2001, The Lancet.

[8]  C. Kelly,et al.  Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea , 2001, The Lancet.

[9]  M. Wilcox,et al.  Hospital disinfectants and spore formation by Clostridium difficile , 2000, The Lancet.

[10]  C. Surawicz,et al.  The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  T. Leet,et al.  Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Boyce.  Using Alcohol for Hand Antisepsis: Dispelling Old Myths , 2000, Infection Control & Hospital Epidemiology.

[13]  F. Barbut,et al.  Epidemiology of Recurrences or Reinfections ofClostridium difficile-Associated Diarrhea , 2000, Journal of Clinical Microbiology.

[14]  A. Limaye,et al.  Pseudomembranous Colitis Caused by a Toxin A− B+ Strain of Clostridium difficile , 2000, Journal of Clinical Microbiology.

[15]  K. Carroll,et al.  Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools. , 2000, Diagnostic microbiology and infectious disease.

[16]  C. Kelly,et al.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. , 2000, The New England journal of medicine.

[17]  P. Rooney,et al.  Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: a study of 284 admissions of elderly patients to six general hospitals in Wales. , 1999, The Journal of hospital infection.

[18]  M. Samore.  Epidemiology of nosocomial clostridium difficile diarrhoea. , 1999, The Journal of hospital infection.

[19]  M. Alfa,et al.  An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. , 1999, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[20]  S. Meyers.  Clostridium difficile Colitis , 1999, American Journal of Gastroenterology.

[21]  D. O'neill,et al.  Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. , 1999, Age and ageing.

[22]  P. Mennonna,et al.  Effectiveness of infection control program in controlling nosocomial Clostridium difficile. , 1998, American journal of infection control.

[23]  D. Yadav,et al.  Clostridium difficile colitis: factors influencing treatment failure and relapse—a prospective evaluation , 1998, American Journal of Gastroenterology.

[24]  M. Alfa,et al.  Survey of Incidence of Clostridium difficile Infection in Canadian Hospitals and Diagnostic Approaches , 1998, Journal of Clinical Microbiology.

[25]  P. Coudron,et al.  Hospital-wide Restriction of Clindamycin: Effect on the Incidence of Clostridium difficile-Associated Diarrhea and Cost , 1998, Annals of Internal Medicine.

[26]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Fridkin,et al.  Risk factors for early recurrent Clostridium difficile-associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  R. E. Barry,et al.  The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. , 1998, The Journal of infection.

[29]  M. Samore,et al.  Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea , 1998, The Lancet.

[30]  J. Silva,et al.  Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C. difficile-associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  R N Baldwin,et al.  Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. , 1997, The Journal of antimicrobial chemotherapy.

[32]  M. Samore,et al.  Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals. , 1997, The Journal of infectious diseases.

[33]  R. Fekety.  Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. , 1997, The American journal of gastroenterology.

[34]  C. Surawicz,et al.  Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  M. Mulligan,et al.  Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  J. Bartlett,et al.  Treatment of Relapsing Clostridium difficile Diarrhea with Lactobacillus GG , 1996 .

[37]  M. Samore,et al.  Comparison of arbitrarily-primed polymerase chain reaction, restriction enzyme analysis and pulsed-field gel electrophoresis for typing Clostridium difficile☆ , 1996 .

[38]  W. Graninger,et al.  Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  C. Pitchumoni,et al.  Prognostic criteria in Clostridium difficile colitis. , 1996, The American journal of gastroenterology.

[40]  Philip Smith,et al.  Antimicrobial Use in Long-Term–Care Facilities , 1996, Infection Control & Hospital Epidemiology.

[41]  J. Starr,et al.  Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime , 1995, BMJ.

[42]  Raymond J. Hauser,et al.  Acute gastroenteritis in three community-based nursing homes. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[43]  M. Gilchrist.  Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.

[44]  D. Gerding,et al.  Effectiveness of Liquid Soap vs. Chlorhexidine Gluconate for the Removal of Clostridium difficile from Bare Hands and Gloved Hands , 1994, Infection Control & Hospital Epidemiology.

[45]  M. Samore,et al.  Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains , 1994, Journal of clinical microbiology.

[46]  C. Surawicz,et al.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. , 1994, JAMA.

[47]  D. Gerding,et al.  Ten Years of Prospective Clostridium difficile-Associated Disease Surveillance and Treatment at the Minneapolis VA Medical Center, 1982–1991 , 1994, Infection Control & Hospital Epidemiology.

[48]  J. Bartlett.  Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  R. Fekety,et al.  Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea. , 1994, Diagnostic microbiology and infectious disease.

[50]  E. P. Dellinger,et al.  Consensus Development of Quality Standards , 1994, Infection Control & Hospital Epidemiology.

[51]  D. Gerding,et al.  Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.

[52]  K. Tsimidis,et al.  Infection due to Clostridium difficile among elderly residents of a long-term-care facility. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  J. Rotschafer,et al.  Clostridium difficile Colonization in Residents of Long‐Term Care Facilities: Prevalence and Risk Factors , 1993, Journal of the American Geriatrics Society.

[54]  D. Gerding,et al.  Optimal methods for identifying Clostridium difficile infections. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  Fausto,et al.  Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea , 1992, Antimicrobial Agents and Chemotherapy.

[56]  L. Peterson,et al.  Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or Metronidazole , 1992, Annals of Internal Medicine.

[57]  G. Doern,et al.  Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays , 1992, Journal of Clinical Microbiology.

[58]  V. Khanna,et al.  Nosocomial diarrhoea due to a single strain of Clostridium difficile: a prolonged outbreak in elderly patients. , 1992, Age and ageing.

[59]  J. Sisler,et al.  Lack of care giver hand contamination with endemic bacterial pathogens in a nursing home. , 1992, American journal of infection control.

[60]  N. Schupf,et al.  Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. , 1992, Infection control and hospital epidemiology.

[61]  M. Delmée,et al.  Clostridium difficile infection in a geriatric ward. , 1991, Archives of gerontology and geriatrics.

[62]  M. Delmée,et al.  Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. , 1991, The American journal of medicine.

[63]  M. J. Hall,et al.  Prevalence of Clostridium difficile on a mixed-function ward for the elderly. , 1990, The Journal of infection.

[64]  D. McLaughlin,et al.  Control of Clostridium difficile colitis outbreak by treating asymptomatic carriers with metronidazole. , 1990, American journal of infection control.

[65]  C. Surawicz,et al.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. , 1990, The Journal of infectious diseases.

[66]  L. Peterson,et al.  Nosocomial Clostridium difficile colonisation and disease , 1990, The Lancet.

[67]  G. Talbot,et al.  Risk factors for Clostridium difficile toxin-associated diarrhea. , 1990, Infection control and hospital epidemiology.

[68]  J. Hotz.  [Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study]. , 1990, Zeitschrift fur Gastroenterologie.

[69]  J. Bartlett,et al.  Postantibiotic Colonization with Clostridium difficile in Nursing Home Patients , 1990, Journal of the American Geriatrics Society.

[70]  L. Peterson,et al.  Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. , 1990, The American journal of medicine.

[71]  W. Greenough,et al.  PROTEIN-LOSING ENTEROPATHY ASSOCIATED WITH CLOSTRIDIUM DIFFICILE INFECTION , 1989, The Lancet.

[72]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[73]  K. Wilson,et al.  Acquisition of Clostridium difficile from the hospital environment. , 1988, American journal of epidemiology.

[74]  T. Elliott,et al.  Gastrointestinal carriage rate of Clostridium difficile in elderly, chronic care hospital patients. , 1988, The Journal of hospital infection.

[75]  B. Goldin,et al.  SUCCESSFUL TREATMENT OF RELAPSING CLOSTRIDIUM DIFFICILE COLITIS WITH LACTOBACILLUS GG , 1987, The Lancet.

[76]  R. Fallon,et al.  IS CLOSTRIDIUM DIFFICILE ENDEMIC IN CHRONIC-CARE FACILITIES? , 1987, The Lancet.

[77]  J. Silva,et al.  Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. , 1987, Journal of clinical gastroenterology.

[78]  J. Bartlett,et al.  IS CLOSTRIDIUM DIFFICILE ENDEMIC IN CHRONIC-CARE FACILITIES? , 1986, The Lancet.

[79]  M. Dudley,et al.  Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. , 1986, Archives of internal medicine.

[80]  M. McDonald,et al.  Antibiotic‐associated colitis caused by Clostridium difficile: relapse and risk factors , 1986, The Medical journal of Australia.

[81]  D. Gordon,et al.  Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. , 1985, Gastroenterology.

[82]  R. Möllby,et al.  Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. , 1985, The Journal of infectious diseases.

[83]  P. Millard,et al.  Clostridium difficile diarrhoea: a highly infectious organism. , 1984, Age and ageing.

[84]  D. Gerding,et al.  PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.

[85]  R. Yolken,et al.  Serum antibody response to toxins A and B of Clostridium difficile. , 1983, The Journal of infectious diseases.

[86]  A. Savage,et al.  Nosocomial Spread of Clostridium Difficile , 1983, Infection Control.

[87]  J. Nash,et al.  Clostridium difficile and cytotoxin in routine faecal specimens. , 1982, Journal of clinical pathology.

[88]  J. Bartlett.  Antibiotic-associated pseudomembranous colitis. , 1981, Reviews of infectious diseases.

[89]  J. Silva,et al.  Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. , 1981, The American journal of medicine.

[90]  S. Nakamura,et al.  Isolation of Clostridium difficile from the Feces and the Antibody in Sera of Young and Elderly Adults , 1981, Microbiology and immunology.

[91]  H. Murray,et al.  Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. , 1979, American journal of hospital pharmacy.

[92]  D. Gerding.  Treatment of Clostridium difficile-associated diarrhea and colitis. , 2000, Current topics in microbiology and immunology.

[93]  K. Tullus,et al.  A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[94]  M. Samore,et al.  Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. , 1996, The American journal of medicine.

[95]  E. Larson,et al.  APIC guideline for handwashing and hand antisepsis in health care settings. , 1995, American journal of infection control.

[96]  K. Riederer,et al.  Diagnosis of Clostridium difficile associated diarrhea: comparison of three rapid methods employing different markers for detection. , 1995, Canadian journal of microbiology.

[97]  R. Platt,et al.  Epidemiology of community-acquired Clostridium difficile-associated diarrhea. , 1994, The Journal of infectious diseases.

[98]  K. Lillemoe,et al.  Pseudomembranous colitis: a surgical disease? , 1994, Surgery.

[99]  R. Bennett,et al.  C difficile diarrhea: a common--and overlooked--nursing home infection. , 1990, Geriatrics.

[100]  G. Wilcock,et al.  Clostridium difficile in acute and long-stay elderly patients. , 1988, Age and ageing.

[101]  R. Möllby,et al.  Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden. , 1984, The Journal of antimicrobial chemotherapy.